The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Sphingolipid lysosomal storage disorders
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Foust, K. D., Wang, X., McGovern, V. L., Braun, L., Bevan, A. K., Haidet, A. M., Le, T. T., Morales, P. R., Rich, M. M., Burghes, A. H. M., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1610 · Cited by 688
RetractedThe Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
The metabolic and molecular bases of inherited disease
Chen, Y.-T. (2001) · Medical Entomology and Zoology · Cited by 6,928
Wiederschain, G. Y. (2009) · Biochemistry (Moscow) · doi:10.1134/s0006297909090156 · Cited by 4,083
A Gene Network Regulating Lysosomal Biogenesis and Function
Sardiello, M., Palmieri, M., di Ronza, A., Medina, D. L., Valenza, M., Gennarino, V. A., Di Malta, C., Donaudy, F., Embrione, V., Polishchuk, R. S., et al. (2009) · Science · doi:10.1126/science.1174447 · Cited by 2,543
Varki, A. P., Cummings, R. D., Esko, J. D., Freeze, H. H., Stanley, P., Bertozzi, C. R., Hart, G. W., & Etzler, M. E. (1999) · Cited by 2,384
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
Sidransky, E., Nalls, M. A., Aasly, J. O., Aharon-Peretz, J., Annesi, G., Barbosa, E. R., Bar-Shira, A., Berg, D., Bras, J., Brice, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901281 · Cited by 2,135
The role of autophagy in neurodegenerative disease
Nixon, R. A. (2013) · Nature Medicine · doi:10.1038/nm.3232 · Cited by 2,059
Holler, N., Zaru, R., Micheau, O., Thome, M., Attinger, A., Valitutti, S., Bodmer, J.-L., Schneider, P., Seed, B., & Tschopp, J. (2000) · Nature Immunology · doi:10.1038/82732 · Cited by 1,938
Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function
Saftig, P., & Klumperman, J. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2745 · Cited by 1,648
Catalytic activity of the caspase-8–FLIPL complex inhibits RIPK3-dependent necrosis
Oberst, A., Dillon, C. P., Weinlich, R., McCormick, L. L., Fitzgerald, P., Pop, C., Hakem, R., Salvesen, G. S., & Green, D. R. (2011) · Nature · doi:10.1038/nature09852 · Cited by 1,278
Vanier, M. T. (2010) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-5-16 · Cited by 1,222
Linkermann, A., & Green, D. R. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1310050 · Cited by 1,103
Plasma Membrane Repair Is Mediated by Ca2+-Regulated Exocytosis of Lysosomes
Reddy, A., Caler, E. V., & Andrews, N. W. (2001) · Cell · doi:10.1016/s0092-8674(01)00421-4 · Cited by 1,042
Autophagy and apoptosis dysfunction in neurodegenerative disorders
Ghavami, S., Shojaei, S., Yeganeh, B., Ande, S. R., Jangamreddy, J. R., Mehrpour, M., Christoffersson, J., Chaabane, W., Moghadam, A. R., Kashani, H. H., et al. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.10.004 · Cited by 1,039
Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways
Palmieri, M., Impey, S., Kang, H., di Ronza, A., Pelz, C., Sardiello, M., & Ballabio, A. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr306 · Cited by 1,022
Lloyd-Evans, E., Morgan, A. J., He, X., Smith, D. A., Elliot-Smith, E., Sillence, D. J., Churchill, G. C., Schuchman, E. H., Galione, A., & Platt, F. M. (2008) · Nature Medicine · doi:10.1038/nm.1876 · Cited by 829
Self-citationNecroptosis as an alternative form of programmed cell death
Christofferson, D. E., & Yuan, J. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.12.003 · Cited by 770
Cox, T., Lachmann, R., Hollak, C., Aerts, J., van Weely, S., Hrebícek, M., Platt, F., Butters, T., Dwek, R., Moyses, C., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02161-9 · Cited by 744
Self-citationTranscriptional Activation of Lysosomal Exocytosis Promotes Cellular Clearance
Medina, D. L., Fraldi, A., Bouche, V., Annunziata, F., Mansueto, G., Spampanato, C., Puri, C., Pignata, A., Martina, J. A., Sardiello, M., et al. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.07.016 · Cited by 716
Lysosomal storage disorders: The cellular impact of lysosomal dysfunction
Platt, F. M., Boland, B., & van der Spoel, A. C. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201208152 · Cited by 689
Self-citationMiglustat for treatment of Niemann-Pick C disease: a randomised controlled study
Patterson, M. C., Vecchio, D., Prady, H., Abel, L., & Wraith, J. E. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70194-1 · Cited by 608
Hsp70 stabilizes lysosomes and reverts Niemann–Pick disease-associated lysosomal pathology
Kirkegaard, T., Roth, A. G., Petersen, N. H. T., Mahalka, A. K., Olsen, O. D., Moilanen, I., Zylicz, A., Knudsen, J., Sandhoff, K., Arenz, C., et al. (2010) · Nature · doi:10.1038/nature08710 · Cited by 519
A vital role for glycosphingolipid synthesis during development and differentiation
Yamashita, T., Wada, R., Sasaki, T., Deng, C., Bierfreund, U., Sandhoff, K., & Proia, R. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9142 · Cited by 505
Recommendations for the diagnosis and management of Niemann–Pick disease type C: An update
Patterson, M. C., Hendriksz, C. J., Walterfang, M., Sedel, F., Vanier, M. T., & Wijburg, F. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2012.03.012 · Cited by 475
The return of the nucleus: transcriptional and epigenetic control of autophagy
Füllgrabe, J., Klionsky, D. J., & Joseph, B. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3716 · Cited by 466
N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis.
Platt, F. M., Neises, G. R., Dwek, R. A., & Butters, T. D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37202-2 · Cited by 455
Self-citationDavidson, C. D., Ali, N. F., Micsenyi, M. C., Stephney, G., Renault, S., Dobrenis, K., Ory, D. S., Vanier, M. T., & Walkley, S. U. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006951 · Cited by 449
Occurrence of Parkinson's syndrome in type 1 Gaucher disease
Neudorfer, O., Giladi, N., Elstein, D., Abrahamov, A., Turezkite, T., Aghai, E., Reches, A., Bembi, B., & Zimran, A. (1996) · QJM · doi:10.1093/qjmed/89.9.691 · Cited by 401
Simpson, M. A., Cross, H., Proukakis, C., Priestman, D. A., Neville, D. C. A., Reinkensmeier, G., Wang, H., Wiznitzer, M., Gurtz, K., Verganelaki, A., et al. (2004) · Nature Genetics · doi:10.1038/ng1460 · Cited by 389
Self-citationJaiswal, J. K., Andrews, N. W., & Simon, S. M. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200208154 · Cited by 386
Common and Uncommon Pathogenic Cascades in Lysosomal Storage Diseases
Vitner, E. B., Platt, F. M., & Futerman, A. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.134452 · Cited by 369
Self-citationLysosomal impairment in Parkinson's disease
Dehay, B., Martinez‐Vicente, M., Caldwell, G. A., Caldwell, K. A., Yue, Z., Cookson, M. R., Klein, C., Vila, M., & Bezard, E. (2013) · Movement Disorders · doi:10.1002/mds.25462 · Cited by 340
Tayebi, N. (2003) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(03)00071-4 · Cited by 327
Critical role for glycosphingolipids in Niemann-Pick disease type C
Zervas, M., Somers, K. L., Thrall, M. A., & Walkley, S. U. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00396-7 · Cited by 324
Transmembrane Molecular Pump Activity of Niemann-Pick C1 Protein
Davies, J. P., Chen, F. W., & Ioannou, Y. A. (2000) · Science · doi:10.1126/science.290.5500.2295 · Cited by 319
Gaucher disease: pathological mechanisms and modern management
Jmoudiak, M., & Futerman, A. H. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05351.x · Cited by 288
Sano, R., Annunziata, I., Patterson, A., Moshiach, S., Gomero, E., Opferman, J., Forte, M., & d'Azzo, A. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.10.021 · Cited by 288
ZKSCAN3 Is a Master Transcriptional Repressor of Autophagy
Chauhan, S., Goodwin, J. G., Chauhan, S., Manyam, G., Wang, J., Kamat, A. M., & Boyd, D. D. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.024 · Cited by 266
3 Gaucher's disease: clinical features and natural history
Cox, T. M., & Schofield, J. P. (1997) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(97)80033-9 · Cited by 260
Enzyme Replacement for Lysosomal Diseases
Brady, R. O. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.57.110104.115650 · Cited by 254
Clarifying lysosomal storage diseases
Schultz, M. L., Tecedor, L., Chang, M., & Davidson, B. L. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.05.006 · Cited by 245
Niemann‐Pick type C disease: molecular mechanisms and potential therapeutic approaches
Rosenbaum, A. I., & Maxfield, F. R. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06976.x · Cited by 232
Glucocerebrosidase mutations are an important risk factor for Lewy body disorders
Goker-Alpan, O., Giasson, B. I., Eblan, M. J., Nguyen, J., Hurtig, H. I., Lee, V. M.-Y., Trojanowski, J. Q., & Sidransky, E. (2006) · Neurology · doi:10.1212/01.wnl.0000230215.41296.18 · Cited by 230
Ceramide synthases as potential targets for therapeutic intervention in human diseases
Park, J.-W., Park, W.-J., & Futerman, A. H. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.08.019 · Cited by 229
Wenger, D. A., Rafi, M. A., & Luzi, P. (1997) · Human Mutation · doi:10.1002/(sici)1098-1004(1997)10:4<268::aid-humu2>3.0.co;2-d · Cited by 223
Lipids on Trial: The Search for the Offending Metabolite in Niemann-Pick type C Disease
Lloyd-Evans, E., & Platt, F. M. (2010) · Traffic · doi:10.1111/j.1600-0854.2010.01032.x · Cited by 202
Self-citationGaucher Disease and Parkinsonism: A Phenotypic and Genotypic Characterization
Tayebi, N., Callahan, M., Madike, V., Stubblefield, B. K., Orvisky, E., Krasnewich, D., Fillano, J. J., & Sidransky, E. (2001) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2001.3201 · Cited by 200
Ioannou, Y. A., Zeidner, K. M., Gordon, R. E., & Desnick, R. J. (2001) · The American Journal of Human Genetics · doi:10.1086/316953 · Cited by 200
Alteration of Ganglioside Biosynthesis Responsible for Complex Hereditary Spastic Paraplegia
Boukhris, A., Schule, R., Loureiro, J. L., Lourenço, C. M., Mundwiller, E., Gonzalez, M. A., Charles, P., Gauthier, J., Rekik, I., Acosta Lebrigio, R. F., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.05.006 · Cited by 184
Biosynthesis and degradation of mammalian glycosphingolipids
Sandhoff, K., & Kolter, T. (2003) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2003.1265 · Cited by 183
Deletion of macrophage-inflammatory protein 1α retards neurodegeneration in Sandhoff disease mice
Wu, Y.-P., & Proia, R. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400625101 · Cited by 182
Liu, B., Ramirez, C. M., Miller, A. M., Repa, J. J., Turley, S. D., & Dietschy, J. M. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m000257 · Cited by 172
Niemann-Pick disease type C symptomatology: an expert-based clinical description
Mengel, E., Klünemann, H.-H., Lourenço, C. M., Hendriksz, C. J., Sedel, F., Walterfang, M., & Kolb, S. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-166 · Cited by 170
Niemann–Pick Type C Mutations Cause Lipid Traffic Jam
Liscum, L. (2000) · Traffic · doi:10.1034/j.1600-0854.2000.010304.x · Cited by 168
Beneficial effects of anti-inflammatory therapy in a mouse model of Niemann-Pick disease type C1
Smith, D. A., Wallom, K., Williams, I. M., Jeyakumar, M., & Platt, F. M. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.010 · Cited by 166
Self-citationWraith, J. E. (2002) · Seminars in Neonatology · doi:10.1053/siny.2001.0088 · Cited by 166
RIPK3 as a potential therapeutic target for Gaucher's disease
Vitner, E. B., Salomon, R., Farfel-Becker, T., Meshcheriakova, A., Ali, M., Klein, A. D., Platt, F. M., Cox, T. M., & Futerman, A. H. (2014) · Nature Medicine · doi:10.1038/nm.3449 · Cited by 164
Self-citationEffective gene therapy in an authentic model of Tay-Sachs-related diseases
Cachón-González, M. B., Wang, S. Z., Lynch, A. G., Ziegler, R. J., Cheng, S. H., & Cox, T. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603765103 · Cited by 161
Ramirez, C. M., Liu, B., Taylor, A. M., Repa, J. J., Burns, D. K., Weinberg, A. G., Turley, S. D., & Dietschy, J. M. (2010) · Pediatric Research · doi:10.1203/pdr.0b013e3181ee4dd2 · Cited by 158
Platt, F. M., & Jeyakumar, M. (2008) · Acta Paediatrica · doi:10.1111/j.1651-2227.2008.00656.x · Cited by 157
Self-citationLysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond
Shachar, T., Bianco, C. L., Recchia, A., Wießner, C., Raas‐Rothschild, A., & Futerman, A. H. (2011) · Movement Disorders · doi:10.1002/mds.23774 · Cited by 156
Ellinwood, N. M., Ausseil, J., Desmaris, N., Bigou, S., Liu, S., Jens, J. K., Snella, E. M., Mohammed, E. E., Thomson, C., Raoul, S., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.265 · Cited by 146
Mutations in B4GALNT1 (GM2 synthase) underlie a new disorder of ganglioside biosynthesis
Harlalka, G. V., Lehman, A., Chioza, B. A., Baple, E. L., Maroofian, R., Cross, H. E., Sreekantan-Nair, A., Priestman, D. A., Al-Turki, S., McEntagart, M., et al. (2013) · Brain · doi:10.1093/brain/awt270 · Cited by 146
Self-citationvan der Beek, N. A. M. E., de Vries, J. M., Hagemans, M. L. C., Hop, W. C. J., Kroos, M. A., Wokke, J. H. J., de Visser, M., van Engelen, B. G. M., Kuks, J. B. M., van der Kooi, A. J., et al. (2012) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-7-88 · Cited by 142
Gaucher’s disease with Parkinson’s disease
Bembi, B., Marsala, S. Z., Sidransky, E., Ciana, G., Carrozzi, M., Zorzon, M., de Martini, C. C., Gioulis, M., Pittis, M. G., & Capus, L. (2003) · Neurology · doi:10.1212/01.wnl.0000072482.70963.d7 · Cited by 135
Miglustat: A Review of Its Use in Niemann-Pick Disease Type C
Lyseng-Williamson, K. A. (2013) · Drugs · doi:10.1007/s40265-013-0164-6 · Cited by 125
NSAIDs increase survival in the Sandhoff disease mouse: Synergy with N‐butyldeoxynojirimycin
Jeyakumar, M., Smith, D. A., Williams, I. M., Cortina‐Borja, M., Neville, D. C. A., Butters, T. D., Dwek, R. A., & Platt, F. M. (2004) · Annals of Neurology · doi:10.1002/ana.20242 · Cited by 122
Self-citationGaucher disease: insights from a rare Mendelian disorder.
Sidransky, E. (2012) · PubMed · Cited by 121
Jeyakumar, M., Norflus, F., Tifft, C. J., Cortina‐Borja, M., Butters, T. D., Proia, R. L., Perry, V. H., Dwek, R. A., & Platt, F. M. (2001) · Blood · doi:10.1182/blood.v97.1.327 · Cited by 120
Self-citationPlatt, F. M., & Walkley, S. U. (2004) · doi:10.1093/acprof:oso/9780198508786.001.0001 · Cited by 119
Self-citationCyclodextrin Induces Calcium-Dependent Lysosomal Exocytosis
Chen, F. W., Li, C., & Ioannou, Y. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015054 · Cited by 118
Multidrug permeases and subcellular cholesterol transport
Ioannou, Y. A. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35089558 · Cited by 114
Stuck in traffic: an emerging theme in diseases of the nervous system
Neefjes, J., & van der Kant, R. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2013.11.006 · Cited by 112
Enzyme replacement therapy in Fabry disease
Brady, R. O., Murray, G. J., Moore, D. F., & Schiffmann, R. (2001) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1012451320105 · Cited by 110
Animal models of Alzheimer's disease and drug development
Laurijssens, B. E., Aujard, F., & Rahman, A. (2012) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2012.04.001 · Cited by 108
Rahim, A. A., Wong, A. M. S., Hoefer, K., Buckley, S. M. K., Mattar, C. N. Z., Cheng, S. H., Chan, J. K. Y., Cooper, J. D., & Waddington, S. N. (2011) · The FASEB Journal · doi:10.1096/fj.11-182311 · Cited by 102
Cost-effectiveness of enzyme replacement therapy for Fabry disease
Rombach, S. M., Hollak, C. E. M., Linthorst, G. E., & Dijkgraaf, M. G. W. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-29 · Cited by 98
Lysosomal enhancement: A CLEAR answer to cellular degradative needs
Sardiello, M., & Ballabio, A. (2009) · Cell Cycle · doi:10.4161/cc.8.24.10263 · Cited by 96
Stein, V. M., Crooks, A. V., Ding, W., Prociuk, M. L., O’Donnell, P., Bryan, C., Sikora, T. U., Dingemanse, J., Vanier, M. T., Walkley, S. U., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825414a6 · Cited by 94
The Structure and Function of the Niemann–Pick C1 Protein
Ioannou, Y. A. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3061 · Cited by 89
Therapeutic Response in Feline Sandhoff Disease Despite Immunity to Intracranial Gene Therapy
Bradbury, A. M., Cochran, J. N., McCurdy, V. J., Johnson, A. K., Brunson, B. L., Gray‐Edwards, H. L., LeRoy, S. G., Hwang, M., Randle, A. N., Jackson, L. S., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.86 · Cited by 86
Glycosphingolipid functions: insights from engineered mouse models
Proia, R. L. (2003) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2003.1268 · Cited by 85
Pontikis, C., Davidson, C. D., Walkley, S. U., Platt, F. M., & Begley, D. J. (2013) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-012-9583-x · Cited by 83
Self-citationWalterfang, M., Chien, Y., Imrie, J., Rushton, D., Schubiger, D., & Patterson, M. C. (2012) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-7-76 · Cited by 77
Relative acidic compartment volume as a lysosomal storage disorder–associated biomarker
te Vruchte, D., Speak, A. O., Wallom, K. L., Al Eisa, N., Smith, D. A., Hendriksz, C. J., Simmons, L., Lachmann, R. H., Cousins, A., Hartung, R., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72835 · Cited by 73
Self-citationEnzyme replacement therapy: conception, chaos and culmination
Brady, R. O. (2003) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2003.1269 · Cited by 72
Gaucher disease associated with parkinsonism: Four further case reports
Várkonyi, J., Rosenbaum, H., Baumann, N., MacKenzie, J. J., Simon, Z., Aharon‐Peretz, J., Walker, J. M., Tayebi, N., & Sidransky, E. (2002) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.10028 · Cited by 70
Gaucher disease: multiple lessons from a single gene disorder
Beutler, E. (2006) · Acta Paediatrica · doi:10.1080/08035320600619039 · Cited by 63
Gaucher Disease and the Synucleinopathies
Hruska, K. S., Göker-Alpan, Ö., & Sidransky, E. (2006) · BioMed Research International · doi:10.1155/jbb/2006/78549 · Cited by 56
Recent Gene Therapy Advancements for Neurological Diseases
The University of North Carolina at Chapel Hill University Libraries (2013) · PubMed · doi:10.17615/ze6f-8f23 · Cited by 47
Ziegler, R. J., Li, C. Q., Cherry, M., Zhu, Y., Hempel, D. M., van Rooijen, N., Ioannou, Y. A., Desnick, R. J., Goldberg, M. A., Yew, N. S., et al. (2002) · Human Gene Therapy · doi:10.1089/10430340252939041 · Cited by 45
Neufeld, E. F. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.031209.093756 · Cited by 43
Gangliosides help stabilize the brain
Proia, R. L. (2004) · Nature Genetics · doi:10.1038/ng1104-1147 · Cited by 41
Long‐term efficacy of miglustat in paediatric patients with Niemann‐Pick disease type C
Chien, Y., Peng, S. S., Yang, C., Lee, N., Tsai, L., Huang, A., Su, S.-F., Tseng, C. C., & Hwu, W. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-012-9479-9 · Cited by 40
Miglustat: Substrate reduction therapy for glycosphingolipid lysosomal storage disorders
Lachmann, R. (2006) · Drugs of today · doi:10.1358/dot.2006.42.1.937457 · Cited by 37
Late‐onset Tay–Sachs disease: The spectrum of peripheral neuropathy in 30 affected patients
Shapiro, B. E., Logigian, E. L., Kolodny, E. H., & Pastores, G. M. (2008) · Muscle & Nerve · doi:10.1002/mus.21061 · Cited by 37
Spontaneous appearance of Tay–Sachs disease in an animal model
Zeng, B. J., Torres, P., Viner, T. C., Wang, Z. H., Raghavan, S., Alroy, J., Pastores, G. M., & Kolodny, E. H. (2008) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2008.06.010 · Cited by 36
Neurological features of Fabry disease: clinical, pathophysiological aspects and therapy
Bersano, A., Lanfranconi, S., Valcarenghi, C., Bresolin, N., Micieli, G., & Baron, P. (2012) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2012.01661.x · Cited by 35
Clinical aspects and diagnosis
Wraith, J. E. (2004) · doi:10.1093/acprof:oso/9780198508786.003.0003 · Cited by 33
HSP70 and lysosomal storage disorders: novel therapeutic opportunities
Petersen, N. H. T., & Kirkegaard, T. (2010) · Biochemical Society Transactions · doi:10.1042/bst0381479 · Cited by 31
Lessons learnt from animal models: pathophysiology of neuropathic lysosomal storage disorders
Hemsley, K. M., & Hopwood, J. J. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9078-6 · Cited by 28
Tomanin, R., Zanetti, A., Zaccariotto, E., D’Avanzo, F., Bellettato, C. M., & Scarpa, M. (2012) · Acta Paediatrica · doi:10.1111/j.1651-2227.2012.02674.x · Cited by 27
Cost-effectiveness of Enzyme Replacement Therapy for Fabry Disease
Rombach, S. M., Dijkgraaf, M. G. W., Linthorst, G. E., & Hollak, C. E. M. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.11.141 · Cited by 25
Yoshida, K., Ikeda, S., Kawaguchi, K., & Yanagisawa, N. (1994) · Neurology · doi:10.1212/wnl.44.12.2376 · Cited by 24
Jesionek‐Kupnicka, D., Majchrowska, A., Krawczyk, J., Wendorff, J., Barcikowska, M., Lukaszek, S., & Liberski, P. P. (1997) · PubMed · Cited by 21
The case for intrauterine gene therapy
Mattar, C. N. Z., Waddington, S. N., Biswas, A., Davidoff, A. M., Choolani, M. A., Chan, J. K. Y., & Nathwani, A. C. (2012) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2012.06.006 · Cited by 19
Brain glycolipids: insights from genetic modifications of biosynthetic enzymes
Schnaar, R. L. (2005) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198525387.003.0004 · Cited by 16
Competing for the treasure in exceptions
Cox, T. M. (2013) · American Journal of Hematology · doi:10.1002/ajh.23399 · Cited by 12
Spontaneous and engineered mammalian storage disease models
Hopwood, J. J., Crawley, A. C., & Taylor, R. M. (2004) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198508786.003.0011 · Cited by 12
The Concept of Prenatal Gene Therapy
Coutelle, C., & Waddington, S. N. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-873-3_1 · Cited by 5
Les maladies de Niemann-Pick de l’adulte
Sedel, F. (2007) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2007.09.017 · Cited by 3
Calcium homeostasis in lysosomal storage diseases
Futerman, A. H. (2009) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp48006 · Cited by 3
Prasad (1999) · doi:10.1002/(sici)1096-8652(199907)61:3
Cited by
The Lysosome as a Regulatory Hub
Perera, R. M., & Zoncu, R. (2016) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-111315-125125 · Cited by 660
Understanding Dopaminergic Cell Death Pathways in Parkinson Disease
Michel, P. P., Hirsch, E. C., & Hunot, S. (2016) · Neuron · doi:10.1016/j.neuron.2016.03.038 · Cited by 600
Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy
Proia, R. L., & Hla, T. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76369 · Cited by 528
NPC1 regulates ER contacts with endocytic organelles to mediate cholesterol egress
Höglinger, D., Burgoyne, T., Sanchez-Heras, E., Hartwig, P., Colaco, A., Newton, J., Futter, C. E., Spiegel, S., Platt, F. M., & Eden, E. R. (2019) · Nature Communications · doi:10.1038/s41467-019-12152-2 · Cited by 299
Self-citationMiranda, A. M., Lasiecka, Z. M., Xu, Y., Neufeld, J., Shahriar, S., Simoes, S., Chan, R. B., Oliveira, T. G., Small, S. A., & Di Paolo, G. (2018) · Nature Communications · doi:10.1038/s41467-017-02533-w · Cited by 226
Metadata
- Authors
- Platt, F. M.
- Venue
- Nature
- Published
- 2014-06
- Volume
- 510
- Issue
- 7503
- Pages
- 68-75
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1995863785
- Cited by
- 320
- References
- 114
- FWCI
- 19.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.